Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.74B
Enterprise Value11.75B
P/E Ratio14.38
PEG Ratio2.71
Price/Sales Ratio2.86
Price/Book Ratio3.1
Enterprise/Revenue2.82
Enterprise/EBITDA11.54

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.2
Operating Margin0.22
AD

Management Effectiveness

Return On Assets0.13
Return On Equity0.24

Income Statement

Revenue3.85B
Revenue/Share6.99
Gross Profit3.08B
EBITDA981.94M
Net Income759.5M
Diluted EPS1.34

Balance Sheet

Total Cash743.76M
Total Cash/Share1.31
Total Debt279.19M
Total Debt/Equity0.08
Current Ratio1.17
Book Value Per Share6.51

Price History

52-Week Change-10.84
52-Week High24.75
52-Week Low19.16
Moving Average 50 Days21.58
Moving Average 200 Days21.84

Statistics

Average Volume7.33M
Shares Outstanding567.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.1
Trailing Annual Dividend Yield5.5
Payout Ratio1.29
Last Split Factor3:2
Last Split DateJuly 02, 2014
AD